Skip to main content
. Author manuscript; available in PMC: 2017 Jun 5.
Published in final edited form as: Open Access J Clin Trials. 2016 Dec 22;9:1–10. doi: 10.2147/OAJCT.S105010

Table 2.

Baseline characteristics of healthy women enrolled in the study of intravaginal curcumin, overall and by curcumin dose (n=13)

Characteristics Overall (n=13) 500 mg (n=3) 1,000 mg (n=3) 1,500 mg (n=3) 2,000 mg (n=4)
Ethnicity
 Hispanic 2/13 (15.4%) 1/3 (33.3%) 1/3 (66.7%) 0/3 (0.0%) 0/4 (0.0%)
Race
 Asian 1/13 (7.7%) 1/3 (33.3%) 0/3 (0.0%) 0/3 (0.0%) 0/4 (0.0%)
 Black 6/13 (46.2%) 0/3 (0.0%) 1/3 (33.3%) 2/3 (66.7%) 3/4 (75.0%)
 Other 2/13 (15.4%) 1/3 (33.3%) 1/3 (33.3%) 0/3 (0.0%) 0/4 (0.0%)
 White 4/13 (30.8%) 1/3 (33.3%) 1/3 (33.3%) 1/3 (33.3%) 1/4 (25.0%)
Partner status
 No partner 3/13 (23.1%) 0/3 (0.0%) 1/3 (33.3%) 1/3 (33.3%) 1/4 (25.0%)
 Living with a partner 6/13 (46.2%) 1/3 (33.3%) 1/3 (33.3%) 1/3 (33.3%) 3/4 (75.0%)
 Not living with a partner 4/13 (30.8%) 2/3 (66.7%) 1/3 (33.3%) 1/3 (33.3%) 0/4 (0.0%)
Age, mean (SD) 28.8 (7.6) 27.2 (10.4) 28.2 (6.2) 23.8 (2.9) 34.0 (7.9)

Note: Data shown as number (%) or mean (SD).